CI Canadian Convertible Bond ETF Common (TSE:CXF – Get Free Report)’s stock price fell 0.5% during trading on Tuesday . The stock traded as low as C$9.76 and last traded at C$9.85. 26,083 shares changed hands during mid-day trading, an increase of 455% from the average session volume of 4,697 shares. The stock had previously closed at C$9.90.
CI Canadian Convertible Bond ETF Common Stock Performance
The company’s fifty day moving average is C$10.11 and its 200-day moving average is C$10.11.
CI Canadian Convertible Bond ETF Common Company Profile
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company’s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Featured Stories
- Five stocks we like better than CI Canadian Convertible Bond ETF Common
- What is the Dow Jones Industrial Average (DJIA)?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Use Stock Screeners to Find Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for CI Canadian Convertible Bond ETF Common Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Canadian Convertible Bond ETF Common and related companies with MarketBeat.com's FREE daily email newsletter.
